Laurus Labs Limited

BSE: LAURUSLABS540222ISIN INE947Q01028

Healthcare
Pharmaceuticals
BSE 500

Share price

₹2,306.10-13.90 (-0.60%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹2,442.00
52W low: ₹913.35
Off 52W high: -5.57%
1M return: +17.42%
3M return: +25.15%
6M return: +96.01%
1Y return: +134.59%
20D avg volume: 1,37,080
50 DMA: ₹2,011.55
200 DMA: ₹1,468.13

Key ratios Consolidated

Market cap: ₹1,24,601 Cr
Current price: ₹2,306.10
52W high / low: ₹2,442.00 / ₹913.35
Face value: ₹2.00
P/E: 93.53
P/B: 20.56
EPS (TTM): ₹24.66
Book value / share: ₹112.17
ROE: —
ROCE: 19.70%
Operating margin: —
Net margin: —
Debt / equity: 0.44
Net debt: ₹2,285 Cr
Interest cover: 7.92
Dividend yield: 0.05%
Dividend / share (TTM): ₹1.20
Payout: 4.87%
Cash conversion cycle: 173.9 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	2,206	2,026	1,812	1,778	1,653	1,570	1,720	1,415	1,224	1,195	1,440	1,195
	13.01	9.18	11.80	5.76	26.96	10.43	58.57	9.42	4.60	2.51	18.53	2.43
	2,219	2,035	1,823	1,784	1,680	1,580	1,779	1,424	1,228	1,197	1,458	1,197
	1,628	1,554	1,462	1,457	1,411	1,356	1,467	1,294	1,205	1,179	1,351	1,163
	900.69	785.77	792.86	725.32	676.75	599.41	626.33	653.00	577.17	572.05	591.44	634.12
	45.01	35.12	48.24	55.12	30.70	38.50	22.31	34.79	25.59	22.67	40.76	17.54
	265.71	258.70	235.85	229.24	215.56	214.80	177.70	189.12	178.72	173.98	161.11	154.96
	44.10	42.22	40.44	38.79	40.00	51.50	56.40	57.80	52.61	49.19	50.50	50.82
	127.39	123.87	122.10	120.62	120.49	116.84	110.43	106.09	107.51	106.06	102.25	98.41
	374.27	373.33	363.51	374.27	371.21	335.29	339.32	330.63	318.35	312.88	315.06	313.13
	591.82	481.36	361.37	326.56	269.73	224.22	312.34	130.68	22.81	18.46	107.27	34.62
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	591.82	481.36	361.37	326.56	269.73	224.22	312.34	130.68	22.81	18.46	107.27	34.62
	155.08	119.37	79.46	73.45	75.98	63.14	78.47	40.07	5.09	6.25	31.95	9.45
	436.19	362.07	282.09	251.88	194.49	161.68	232.77	92.94	19.95	12.68	75.02	23.34
	8.17	6.81	5.17	4.67	3.61	3.02	4.34	1.71	0.37	0.23	1.40	0.43
Key metrics
	763.31	647.45	523.91	485.97	430.22	392.56	479.17	294.57	182.93	173.71	260.02	183.85
	34.60%	32.00%	28.90%	27.30%	26.00%	25.00%	27.90%	20.80%	14.90%	14.50%	18.10%	15.40%
	19.80%	17.90%	15.60%	14.20%	11.80%	10.30%	13.50%	6.60%	1.60%	1.10%	5.20%	2.00%
	8.40%	—	5.80%	—	5.00%	—	6.40%	—	—	—	—	—
	33.40%	29.10%	5.30%	25.70%	35.10%	31.40%	19.50%	18.40%	—	—	—	—
	124.30%	123.90%	21.20%	171.00%	874.90%	1,175.10%	210.30%	298.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	7,823	6,813	5,554	5,041	6,041	4,936	4,814	2,832	2,292	2,069
	39.75	54.95	75.10	26.34	6.00	15.30	23.66	5.92	16.15	29.19
	7,862	6,868	5,629	5,067	6,047	4,951	4,837	2,838	2,308	2,098
	6,101	5,686	5,145	4,831	4,938	3,867	3,536	2,544	2,188	1,861
	3,205	2,794	2,429	2,422	2,597	2,269	2,359	1,614	1,245	1,061
	183.49	172.56	105.36	110.92	155.71	145.81	96.23	15.88	22.38	27.02
	989.50	895.45	719.52	639.93	580.64	501.53	434.09	344.87	289.20	258.05
	165.55	170.73	216.00	182.90	165.17	102.39	68.16	89.59	88.19	79.64
	493.98	480.05	430.09	384.58	324.08	251.49	205.07	187.27	164.19	—
	1,485	1,444	1,301	1,191	1,093	817.84	670.55	508.90	411.09	321.10
	1,761	1,182	484.29	236.36	1,109	1,084	1,301	293.61	119.75	237.42
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	1,761	1,182	484.29	236.36	1,109	1,084	1,301	293.61	119.75	237.42
	427.36	292.03	129.88	68.15	312.30	251.42	317.29	38.34	25.99	69.81
	1,332	890.14	358.34	162.27	793.43	832.23	983.82	255.27	93.76	167.61
	24.82	16.47	6.65	2.98	14.69	15.42	18.36	23.93	8.83	—
Key metrics
	2,421	1,833	1,130	803.84	1,598	1,438	1,574	570.47	372.13	317.06
	30.94%	26.90%	20.40%	15.90%	26.50%	29.10%	32.70%	20.10%	16.20%	15.30%
	17.03%	13.10%	6.50%	3.20%	13.10%	16.90%	20.40%	9.00%	4.10%	8.10%
	—	19.70%	12.10%	—	—	—	—	—	—	—
	23.03%	22.70%	10.20%	-16.60%	22.40%	2.50%	70.00%	23.60%	10.80%	—
	95.38%	148.40%	120.80%	-79.50%	-4.70%	-15.40%	285.40%	172.30%	-44.10%	—
	—	553.55	-39.35	—	—	—	—	—	—	—
	—	1.82	1.68	—	—	—	—	—	—	—
	—	0.44	0.59	—	—	—	—	—	—	—
	—	2,285	2,594	—	—	—	—	—	—	—
	—	173.9	196.2	—	—	—	—	—	—	—
Balance sheet
	—	10,511	9,336	—	—	—	—	—	—	—
	—	4,829	4,332	—	—	—	—	—	—	—
	—	112.66	99.54	—	—	—	—	—	—	—
	—	2,155	2,007	—	—	—	—	—	—	—
	—	2,342	1,937	—	—	—	—	—	—	—
	—	214.17	237.62	—	—	—	—	—	—	—
	—	3,873	3,668	—	—	—	—	—	—	—
	—	1,252	958.49	—	—	—	—	—	—	—
	—	3,635	3,540	—	—	—	—	—	—	—
	—	2,397	2,693	—	—	—	—	—	—	—
	—	1,786	2,048	—	—	—	—	—	—	—
	—	611.34	645.58	—	—	—	—	—	—	—
	—	5,431	4,603	—	—	—	—	—	—	—
Cash flow
	—	1,624	601.65	—	—	—	—	—	—	—
	—	-1,089	-681.72	—	—	—	—	—	—	—
	—	-524.72	39.28	—	—	—	—	—	—	—
	—	1,070	641.00	—	—	—	—	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	2,014	1,757	1,580	1,509	1,567	1,433	1,650	1,265	1,185	1,117	1,415	1,132
	24.72	20.07	13.09	14.37	28.45	21.52	72.16	7.12	11.89	9.30	24.09	10.72
	2,039	1,777	1,593	1,524	1,595	1,454	1,722	1,272	1,197	1,126	1,439	1,143
	1,519	1,389	1,334	1,289	1,306	1,243	1,392	1,196	1,139	1,087	1,274	1,086
	887.81	777.51	757.92	649.72	644.40	572.89	604.44	628.75	581.24	556.95	579.97	627.97
	45.01	35.12	48.24	55.12	30.70	38.50	22.31	34.79	25.59	22.67	40.76	17.54
	230.76	216.00	199.36	196.29	182.31	179.90	148.77	161.70	148.94	149.23	138.00	133.59
	38.02	35.20	33.91	31.48	33.68	43.89	48.60	48.02	44.69	40.89	41.99	37.56
	97.69	95.76	95.17	94.31	95.59	93.57	88.19	88.66	90.94	91.00	88.90	86.84
	346.82	324.02	330.36	341.60	345.11	315.26	324.96	296.27	293.24	286.35	289.03	292.47
	519.62	388.17	259.37	234.44	288.84	211.44	330.20	76.72	58.09	38.80	164.31	56.70
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	519.62	388.17	259.37	234.44	288.84	211.44	330.20	76.72	58.09	38.80	164.31	56.70
	131.49	98.21	67.58	59.36	73.17	53.50	78.30	19.45	15.65	10.02	42.99	14.06
	388.13	289.96	191.79	175.08	215.67	157.94	251.90	57.27	42.44	28.78	121.32	42.64
	7.18	5.37	3.55	3.25	3.99	2.93	4.68	1.06	0.79	0.53	2.25	0.79
Key metrics
	655.33	519.13	388.45	360.23	418.11	348.90	466.99	213.40	193.72	170.69	295.20	181.10
	32.50%	29.50%	24.60%	23.90%	26.70%	24.40%	28.30%	16.90%	16.30%	15.30%	20.90%	16.00%
	19.30%	16.50%	12.10%	11.60%	13.80%	11.00%	15.30%	4.50%	3.60%	2.60%	8.60%	3.80%
	8.10%	—	4.70%	—	5.50%	—	7.00%	—	—	—	—	—
	28.60%	22.60%	-4.20%	19.30%	32.20%	28.30%	16.60%	11.70%	—	—	—	—
	80.00%	83.60%	-23.90%	205.70%	408.20%	448.80%	107.60%	34.30%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	6,861	6,089	5,217	4,812	5,773	4,707	4,769	2,797	2,236	2,039
	72.25	77.43	100.47	47.42	15.95	21.55	27.32	5.81	16.12	28.84
	6,933	6,166	5,317	4,860	5,789	4,729	4,796	2,803	2,252	2,068
	5,532	5,172	4,814	4,558	4,738	3,753	3,521	2,499	2,131	1,827
	3,073	2,625	2,371	2,397	2,516	2,281	2,375	1,605	1,215	1,054
	183.49	172.56	105.36	110.92	155.71	145.81	96.23	15.88	22.38	27.02
	842.41	757.86	608.64	552.21	496.57	445.14	401.88	324.00	269.72	238.14
	138.61	142.96	182.20	150.82	145.70	95.86	65.92	87.71	85.83	75.44
	382.93	378.64	358.79	345.01	300.58	235.48	196.64	183.85	160.53	121.23
	1,343	1,332	1,201	1,105	1,083	768.14	681.84	500.56	406.04	323.55
	1,402	994.09	503.81	301.47	1,051	975.41	1,275	304.48	121.22	240.91
	0.00	0.00	0.00	—	—	—	—	—	—	—
	1,402	994.09	503.81	301.47	1,051	975.41	1,275	304.48	121.22	240.91
	356.64	253.61	123.42	77.77	291.05	225.32	318.52	37.44	26.23	67.77
	1,045	740.48	380.39	223.70	760.38	750.09	956.11	267.05	94.99	173.14
	19.35	13.72	7.06	4.15	14.14	13.97	17.85	25.03	8.94	—
Key metrics
	1,923	1,516	1,045	797.30	1,498	1,307	1,537	576.04	367.58	437.58
	28.03%	24.90%	20.00%	16.60%	25.90%	27.80%	32.20%	20.60%	16.40%	21.50%
	15.23%	12.20%	7.30%	4.60%	13.20%	15.90%	20.00%	9.50%	4.20%	8.50%
	—	18.10%	12.60%	—	—	—	—	—	—	—
	16.00%	16.70%	8.40%	-16.60%	22.70%	-1.30%	70.50%	25.10%	9.70%	—
	53.04%	94.70%	70.00%	-70.60%	1.40%	-21.50%	258.00%	181.10%	-45.10%	—
	—	670.72	159.38	—	—	—	—	—	—	—
	—	1.87	1.42	—	—	—	—	—	—	—
	—	0.38	0.51	—	—	—	—	—	—	—
	—	1,961	2,274	—	—	—	—	—	—	—
	—	177.5	199.1	—	—	—	—	—	—	—
Balance sheet
	—	9,540	8,587	—	—	—	—	—	—	—
	—	4,363	4,007	—	—	—	—	—	—	—
	—	37.51	50.36	—	—	—	—	—	—	—
	—	2,023	2,035	—	—	—	—	—	—	—
	—	2,136	1,739	—	—	—	—	—	—	—
	—	154.85	162.57	—	—	—	—	—	—	—
	—	2,893	2,763	—	—	—	—	—	—	—
	—	1,197	928.70	—	—	—	—	—	—	—
	—	3,258	3,162	—	—	—	—	—	—	—
	—	1,999	2,325	—	—	—	—	—	—	—
	—	1,621	1,910	—	—	—	—	—	—	—
	—	378.21	414.25	—	—	—	—	—	—	—
	—	5,252	4,564	—	—	—	—	—	—	—
Cash flow
	—	1,385	540.06	—	—	—	—	—	—	—
	—	-847.06	-591.65	—	—	—	—	—	—	—
	—	-550.74	59.32	—	—	—	—	—	—	—
	—	714.23	380.68	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +1.79%
Sales CAGR 5Y: +5.01%
Profit CAGR 3Y: -0.88%
Profit CAGR 5Y: -4.98%
Sales YoY (TTM): +16.00%
Profit YoY (TTM): +53.04%

Consolidated

Sales CAGR 3Y: +4.09%
Sales CAGR 5Y: +7.19%
Profit CAGR 3Y: +3.91%
Profit CAGR 5Y: -1.98%
Sales YoY (TTM): +23.03%
Profit YoY (TTM): +95.38%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 27.48%

Quarter	September 2026	June 2026
Promoter %	27.48%	27.49%

Holder	Type	Holding	Previous	Change
M/s. NSN Holdings (Represented by its Managing Partner, Dr. Satyanarayana Chava)	Promoter	22.97%	22.98%	-0.01%
MIRAE ASSET NIFTY INDIA MANUFACTURING ETF	Public	4.02%	—	—
NEW WORLD FUND INC	Public	3.53%	4.28%	-0.75%
ANUKAR PROJECTS PRIVATE LIMITED	Public	3.24%	3.24%	0.00%
CHUNDURU VENKATA LAKSHMANA RAO	Promoter	2.65%	2.65%	0.00%
SMALLCAP WORLD FUND, INC	Public	2.26%	2.77%	-0.51%
BARCLAYS WEALTH TRUSTEES INDIA PRIVATE LIMITED	Public	1.55%	1.55%	0.00%
AKASH BHANSHALI	Public	1.32%	1.32%	0.00%
M/s. Leven Holdings (Represented by its Managing Partner, Mr. Venkata Ravi Kumar Vantaram)	Promoter	1.15%	1.15%	0.00%
SBI LIFE INSURANCE CO. LTD	Public	1.07%	—	—
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND	Public	1.00%	—	—
SATYANARAYANA CHAVA	Promoter	0.29%	0.29%	0.00%
VENKATA RAVI KUMAR VANTARAM	Promoter	0.19%	0.19%	0.00%
KRISHNAVENI VASIREDDI	Promoter Group	0.04%	0.04%	0.00%
HYMAVATHI VANTARAM	Promoter Group	0.04%	0.04%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%

Filings & corporate actions

Recent announcements

Please see annexed enclosure.3 Nov 2026 · Company Update / Earnings Call Transcript
Please see annexed enclosure.30 Oct 2026 · Company Update / Newspaper Publication
Please see enclosed annexure.29 Oct 2026 · Company Update / Analyst / Investor Meet
Please see enclosed annexure29 Oct 2026 · Company Update / Press Release / Media Release
Please see enclosed annexure29 Oct 2026 · Company Update / Investor Presentation
Please see enclosed annexure29 Oct 2026 · Corp. Action / Dividend
Appointment of Mr. Kundan Kumar Jha as Joint Company Secretary of the Company w.e.f. November 1, 202629 Oct 2026 · Company Update / General
Please see enclosed annexure29 Oct 2026 · Board Meeting / Outcome of Board Meeting
Please see enclosed annexure29 Oct 2026 · Company Update / Acquisition
Please see annexed enclosure29 Oct 2026 · Company Update / Acquisition
Please see annexed enclosure29 Oct 2026 · Result / Financial Results
Please see annexed enclosure.14 Oct 2026 · Company Update / General
Please see annexed enclosure.14 Oct 2026 · Company Update / Acquisition
Please see annexed enclosure.13 Oct 2026 · Company Update / Analyst / Investor Meet
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the un-audited financial results ....13 Oct 2026 · Board Meeting / Board Meeting
Please see annexed enclosure.9 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please see annexed enclosure.6 Oct 2026 · Company Update / Acquisition
Please see annexed enclosure.25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Please see attached enclosure.18 Sep 2026 · Company Update / Investor Presentation
Please see annexed enclosure.15 Sep 2026 · Company Update / Analyst / Investor Meet
Please see annexed enclosure.10 Sep 2026 · Company Update / Analyst / Investor Meet
Please see annexed enclosure.31 Aug 2026 · Company Update / Analyst / Investor Meet
Please see annexed enclosure.12 Aug 2026 · Company Update / Analyst / Investor Meet
Please see annexed enclosure.10 Aug 2026 · Company Update / General
Please see annexed enclosure.30 Jul 2026 · Company Update / Earnings Call Transcript
Please see annexed enclosure.27 Jul 2026 · Company Update / Allotment of ESOP / ESPS
Please see annexed enclosure.25 Jul 2026 · Company Update / General
Please see annexed enclosure.25 Jul 2026 · Company Update / Newspaper Publication
Please see annexed enclosure.24 Jul 2026 · Company Update / Analyst / Investor Meet
Please see annexed enclosure24 Jul 2026 · Company Update / Press Release / Media Release
Please see enclosed annexure24 Jul 2026 · Company Update / Investor Presentation
Please see enclosed annexure24 Jul 2026 · Company Update / Change in Directorate
Please see enclosed annexure24 Jul 2026 · Board Meeting / Outcome of Board Meeting
Please see annexed enclosure24 Jul 2026 · Result / Financial Results
Please see annexed enclosure.14 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please see annexed enclosure.9 Jul 2026 · Company Update / Analyst / Investor Meet
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....9 Jul 2026 · Board Meeting / Board Meeting
Please see annexed annexure.6 Jul 2026 · Company Update / General
Please see annexed enclosure.3 Jul 2026 · Company Update / Credit Rating
Please see annexed enclosure.2 Jul 2026 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Interim Dividend - Rs. - 1.0000	6 Nov 2026	6 Nov 2026	—
Interim Dividend - Rs. - 1.2000	8 May 2026	8 May 2026	—
Interim Dividend - Rs. - 0.8000	31 Oct 2025	31 Oct 2025	—
Interim Dividend - Rs. - 0.8000	9 May 2025	9 May 2025	—
Interim Dividend - Rs. - 0.4000	6 Nov 2024	6 Nov 2024	—

Board meetings

29 Oct 2026 Board Meeting - Financial Results
24 Jul 2026 Board Meeting - Financial Results